Arbutus Biopharma Corp and Genevant Sciences GmbH filed a Stipulation to Extend Time with the U.S. District Court for the District of Delaware in a patent infringement lawsuit against Moderna and a Moderna affiliate regarding the manufacture and sale of MRNA-1273, Moderna's COVID-19 vaccine, requesting an amended case schedule and trial start date of September 24, 2025.